DE60318723T2 - Methode zur quantitativen bestimmung von polynukleotiden in einem gemisch - Google Patents
Methode zur quantitativen bestimmung von polynukleotiden in einem gemisch Download PDFInfo
- Publication number
- DE60318723T2 DE60318723T2 DE60318723T DE60318723T DE60318723T2 DE 60318723 T2 DE60318723 T2 DE 60318723T2 DE 60318723 T DE60318723 T DE 60318723T DE 60318723 T DE60318723 T DE 60318723T DE 60318723 T2 DE60318723 T2 DE 60318723T2
- Authority
- DE
- Germany
- Prior art keywords
- probes
- separation
- sequences
- affinity
- tags
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 194
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 194
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 194
- 238000000034 method Methods 0.000 title claims abstract description 107
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 239000000523 sample Substances 0.000 claims abstract description 450
- 238000000926 separation method Methods 0.000 claims abstract description 81
- 238000009396 hybridization Methods 0.000 claims abstract description 79
- 239000000700 radioactive tracer Substances 0.000 claims abstract description 79
- 238000012360 testing method Methods 0.000 claims abstract description 50
- 239000002773 nucleotide Substances 0.000 claims abstract description 18
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 18
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 230000000694 effects Effects 0.000 claims abstract description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 73
- 108020004414 DNA Proteins 0.000 claims description 46
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 238000001514 detection method Methods 0.000 claims description 28
- 238000003149 assay kit Methods 0.000 claims description 25
- 108020004999 messenger RNA Proteins 0.000 claims description 25
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 238000004949 mass spectrometry Methods 0.000 claims description 22
- 108020004418 ribosomal RNA Proteins 0.000 claims description 18
- 239000012634 fragment Substances 0.000 claims description 17
- 230000000052 comparative effect Effects 0.000 claims description 16
- 230000037230 mobility Effects 0.000 claims description 15
- 238000005194 fractionation Methods 0.000 claims description 14
- 108091034117 Oligonucleotide Proteins 0.000 claims description 13
- 230000000813 microbial effect Effects 0.000 claims description 13
- 230000000295 complement effect Effects 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 238000004020 luminiscence type Methods 0.000 claims description 3
- 210000003705 ribosome Anatomy 0.000 claims description 2
- 238000011277 treatment modality Methods 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims 2
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 239000012491 analyte Substances 0.000 abstract description 65
- 230000003115 biocidal effect Effects 0.000 abstract description 8
- 239000000243 solution Substances 0.000 description 41
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 32
- 108090000623 proteins and genes Proteins 0.000 description 27
- 238000003556 assay Methods 0.000 description 26
- 238000003752 polymerase chain reaction Methods 0.000 description 25
- 241000894006 Bacteria Species 0.000 description 23
- 239000003153 chemical reaction reagent Substances 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 21
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 20
- 230000003321 amplification Effects 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 18
- 239000004170 rice bran wax Substances 0.000 description 18
- 229960002685 biotin Drugs 0.000 description 16
- 235000020958 biotin Nutrition 0.000 description 16
- 239000011616 biotin Substances 0.000 description 16
- 238000010828 elution Methods 0.000 description 16
- 239000007787 solid Substances 0.000 description 15
- 241001504639 Alcedo atthis Species 0.000 description 14
- 238000001962 electrophoresis Methods 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 13
- 238000005251 capillar electrophoresis Methods 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 241000193450 [Clostridium] symbiosum Species 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 230000003319 supportive effect Effects 0.000 description 12
- 239000006249 magnetic particle Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 241000193452 Clostridium tyrobutyricum Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 9
- 238000002372 labelling Methods 0.000 description 9
- 108020004465 16S ribosomal RNA Proteins 0.000 description 8
- 108010090804 Streptavidin Proteins 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 230000007613 environmental effect Effects 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000002751 oligonucleotide probe Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241001112696 Clostridia Species 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 150000007523 nucleic acids Chemical group 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 238000011002 quantification Methods 0.000 description 6
- -1 2- ((iodoacetyl) amino) ethyl Chemical group 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000001502 gel electrophoresis Methods 0.000 description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 238000004445 quantitative analysis Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 108090001008 Avidin Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000193159 Hathewaya histolytica Species 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000011530 RNeasy Mini Kit Methods 0.000 description 4
- 241000499912 Trichoderma reesei Species 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 230000005291 magnetic effect Effects 0.000 description 4
- 239000011325 microbead Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 241000186567 Romboutsia lituseburensis Species 0.000 description 3
- 241001531188 [Eubacterium] rectale Species 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006287 biotinylation Effects 0.000 description 3
- 238000007413 biotinylation Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000012733 comparative method Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000186560 Blautia coccoides Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108060002716 Exonuclease Proteins 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229910052747 lanthanoid Inorganic materials 0.000 description 2
- 150000002602 lanthanoids Chemical class 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000001915 proofreading effect Effects 0.000 description 2
- 108700022487 rRNA Genes Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical class C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- BRLRJZRHRJEWJY-VCOUNFBDSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[3-[3-(4-azido-2-nitroanilino)propyl-methylamino]propyl]pentanamide Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCN(C)CCCNC1=CC=C(N=[N+]=[N-])C=C1[N+]([O-])=O BRLRJZRHRJEWJY-VCOUNFBDSA-N 0.000 description 1
- LWXHLNHAYCDUGT-UHFFFAOYSA-N 5-phenylmethoxy-1h-pyrazole Chemical class C=1C=CC=CC=1COC=1C=CNN=1 LWXHLNHAYCDUGT-UHFFFAOYSA-N 0.000 description 1
- 108020005075 5S Ribosomal RNA Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241000193401 Clostridium acetobutylicum Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000186569 [Clostridium] leptum Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000003838 adenosines Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000009709 capacitor discharge sintering Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003305 oil spill Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 150000003220 pyrenes Chemical class 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011155 quantitative monitoring Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20021325A FI20021325A0 (fi) | 2002-07-05 | 2002-07-05 | Menetelmä ja reagenssipakkaus yksittäisten polynukleotidien määrän määrittämiseksi |
| FI20021325 | 2002-07-05 | ||
| PCT/FI2003/000544 WO2004005545A1 (en) | 2002-07-05 | 2003-07-04 | Method and test kit for quantitative determination of polynucleotides in a mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60318723D1 DE60318723D1 (de) | 2008-03-06 |
| DE60318723T2 true DE60318723T2 (de) | 2009-01-15 |
Family
ID=8564307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60318723T Expired - Lifetime DE60318723T2 (de) | 2002-07-05 | 2003-07-04 | Methode zur quantitativen bestimmung von polynukleotiden in einem gemisch |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7361461B2 (enExample) |
| EP (2) | EP1947200A1 (enExample) |
| JP (1) | JP4672365B2 (enExample) |
| AT (1) | ATE384141T1 (enExample) |
| AU (1) | AU2003242804B2 (enExample) |
| CA (1) | CA2489196C (enExample) |
| DE (1) | DE60318723T2 (enExample) |
| DK (1) | DK1537238T3 (enExample) |
| ES (1) | ES2299727T3 (enExample) |
| FI (1) | FI20021325A0 (enExample) |
| PT (1) | PT1537238E (enExample) |
| WO (1) | WO2004005545A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1851331B1 (fr) * | 2005-02-25 | 2016-02-24 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Procede et dispositif pour separer des cibles moleculaires dans un melange complexe |
| EP1772522A1 (en) * | 2005-10-04 | 2007-04-11 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Control of preservation by biomarkers |
| WO2007093050A1 (en) * | 2006-02-13 | 2007-08-23 | Olga Ornatsky | Gene expression assays conducted by elemental analysis |
| EP2677039B8 (en) | 2006-05-10 | 2022-10-05 | DxTerity Diagnostics Incorporated | Detection of nucleic acid targets using chemically reactive oligonucleotide probes |
| US20090011944A1 (en) * | 2007-02-21 | 2009-01-08 | Valtion Teknillinen Tutkimuskekus | Method and test kit for detecting nucleotide variations |
| FI20075124A0 (fi) * | 2007-02-21 | 2007-02-21 | Valtion Teknillinen | Menetelmä ja testikitti nukleotidivariaatioiden toteamiseksi |
| CA2757300C (en) * | 2009-04-01 | 2018-01-09 | Dxterity Diagnostics Incorporated | Chemical ligation dependent probe amplification (clpa) |
| KR102085242B1 (ko) | 2011-05-17 | 2020-03-05 | 디엑스테리티 다이아그노스틱스 인코포레이티드 | 표적 핵산 검출을 위한 방법 및 조성물 |
| WO2013085631A1 (en) * | 2011-10-25 | 2013-06-13 | The Board Of Regents Of The University Of Texas System | Methods and compositions for identifying enterovirus |
| US9757095B2 (en) | 2014-06-10 | 2017-09-12 | Dxterity Diagnostics Incorporated | Devices and methods for collecting and stabilizing biological samples |
| EP3452618A4 (en) | 2016-05-06 | 2019-12-11 | Regents of the University of Minnesota | ANALYTICAL STANDARDS AND METHOD FOR USE THEREOF |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200313A (en) | 1983-08-05 | 1993-04-06 | Miles Inc. | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
| NZ211453A (en) | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
| US4968602A (en) | 1986-03-05 | 1990-11-06 | Molecular Diagnostics, Inc. | Solution-phase single hybridization assay for detecting polynucleotide sequences |
| AU619170B2 (en) | 1987-01-09 | 1992-01-23 | Abbott Laboratories | Diagnostic assays using nucleic acid probes |
| US5082830A (en) | 1988-02-26 | 1992-01-21 | Enzo Biochem, Inc. | End labeled nucleotide probe |
| US5470705A (en) * | 1992-04-03 | 1995-11-28 | Applied Biosystems, Inc. | Probe composition containing a binding domain and polymer chain and methods of use |
| US5633134A (en) * | 1992-10-06 | 1997-05-27 | Ig Laboratories, Inc. | Method for simultaneously detecting multiple mutations in a DNA sample |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| WO1996006190A2 (en) * | 1994-08-19 | 1996-02-29 | Perkin-Elmer Corporation | Coupled amplification and ligation method |
| AU4729796A (en) | 1994-12-28 | 1996-07-19 | Peter E. Nielsen | Peptide nucleic acid incorporating a chiral backbone |
| DE19516196A1 (de) * | 1995-05-08 | 1996-11-14 | Boehringer Mannheim Gmbh | Verfahren zum quantitativen Nachweis von Nukleinsäuren |
| US6136531A (en) * | 1995-05-08 | 2000-10-24 | Roche Diagnostics Gmbh | Method of quantitatively detecting nucleic acids |
| US5714386A (en) | 1996-01-11 | 1998-02-03 | Board Of Trustees Of The Leland Stanford Junior University | Cy7-allophycocyanin conjugates for use in multiplex fluorescence detection assays |
| CZ228598A3 (cs) * | 1996-01-23 | 1998-12-16 | Rapigene, Inc. | Způsoby a kompozice pro analyzování molekul nukleových kyselin za použití postupu třídění |
| EP2369007B1 (en) | 1996-05-29 | 2015-07-29 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| ATE273381T1 (de) | 1997-02-12 | 2004-08-15 | Eugene Y Chan | Verfahren zur analyse von polymeren |
| KR100414936B1 (ko) | 1997-09-12 | 2004-01-13 | 엑시콘 에이/에스 | 이환 및 삼환 뉴클레오시드, 뉴클레오타이드 및올리고뉴클레오타이드 동족체 |
| WO1999037663A1 (en) | 1998-01-27 | 1999-07-29 | California Institute Of Technology | Method of detecting a nucleic acid |
| WO2000009487A1 (en) * | 1998-08-11 | 2000-02-24 | Bayer Corporation | Near infrared chemiluminescent acridinium compounds and uses thereof |
| US6480791B1 (en) * | 1998-10-28 | 2002-11-12 | Michael P. Strathmann | Parallel methods for genomic analysis |
| EP1161563A2 (en) * | 1999-03-15 | 2001-12-12 | PE Corporation (NY) | Probe/mobility modifier complexes for multiplex nucleic acid detection |
| FI115139B (fi) * | 2001-01-10 | 2005-03-15 | Valtion Teknillinen | Menetelmä ja testipakkaus solu- tai kudosnäytteissä olevien polynukleotidien määrässä tapahtuvien vaihteluiden kvantitatiiviseen ja/tai vertailevaan arvioimiseen |
| AU2002344221A1 (en) * | 2001-05-26 | 2002-12-09 | Aclara Biosciences, Inc. | Catalytic amplification of multiplexed assay signals |
| WO2003033741A1 (en) * | 2001-10-16 | 2003-04-24 | Aclara Biosciences, Inc. | Universal e-tag primer and probe compositions and methods |
| AU2002351193A1 (en) | 2001-11-28 | 2003-06-10 | Mj Bioworks Incorporated | Parallel polymorphism scoring by amplification and error correction |
| CA2500129C (en) | 2002-09-30 | 2011-03-29 | F. Hoffmann-La Roche Ag | Oligonucleotides for genotyping thymidylate synthase gene |
| US7354706B2 (en) | 2003-09-09 | 2008-04-08 | The Regents Of The University Of Colorado, A Body Corporate | Use of photopolymerization for amplification and detection of a molecular recognition event |
| EP1694869A2 (en) | 2003-11-10 | 2006-08-30 | Investigen, Inc. | Methods of preparing nucleic acid for detection |
-
2002
- 2002-07-05 FI FI20021325A patent/FI20021325A0/fi unknown
-
2003
- 2003-07-04 DE DE60318723T patent/DE60318723T2/de not_active Expired - Lifetime
- 2003-07-04 AU AU2003242804A patent/AU2003242804B2/en not_active Ceased
- 2003-07-04 JP JP2004518823A patent/JP4672365B2/ja not_active Expired - Fee Related
- 2003-07-04 AT AT03762698T patent/ATE384141T1/de active
- 2003-07-04 WO PCT/FI2003/000544 patent/WO2004005545A1/en not_active Ceased
- 2003-07-04 ES ES03762698T patent/ES2299727T3/es not_active Expired - Lifetime
- 2003-07-04 PT PT03762698T patent/PT1537238E/pt unknown
- 2003-07-04 CA CA2489196A patent/CA2489196C/en not_active Expired - Fee Related
- 2003-07-04 EP EP08100037A patent/EP1947200A1/en not_active Withdrawn
- 2003-07-04 EP EP03762698A patent/EP1537238B1/en not_active Expired - Lifetime
- 2003-07-04 DK DK03762698T patent/DK1537238T3/da active
- 2003-07-04 US US10/519,403 patent/US7361461B2/en not_active Expired - Fee Related
-
2008
- 2008-04-18 US US12/105,960 patent/US8143388B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8143388B2 (en) | 2012-03-27 |
| AU2003242804A1 (en) | 2004-01-23 |
| AU2003242804B2 (en) | 2008-06-12 |
| CA2489196A1 (en) | 2004-01-15 |
| ATE384141T1 (de) | 2008-02-15 |
| EP1537238B1 (en) | 2008-01-16 |
| FI20021325A0 (fi) | 2002-07-05 |
| US7361461B2 (en) | 2008-04-22 |
| DK1537238T3 (da) | 2008-06-02 |
| ES2299727T3 (es) | 2008-06-01 |
| US20080233591A1 (en) | 2008-09-25 |
| EP1537238A1 (en) | 2005-06-08 |
| CA2489196C (en) | 2013-06-11 |
| EP1947200A1 (en) | 2008-07-23 |
| WO2004005545A1 (en) | 2004-01-15 |
| JP2005532058A (ja) | 2005-10-27 |
| JP4672365B2 (ja) | 2011-04-20 |
| PT1537238E (pt) | 2008-04-22 |
| DE60318723D1 (de) | 2008-03-06 |
| US20060035228A1 (en) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3486467T3 (de) | Verfahren zum Nachweis, Identifizieren und Quantifizieren von Organismen und Viren | |
| DE69902996T2 (de) | Techniken zu detektion von fehlpaarungen | |
| DE69736668T2 (de) | Nukleinsaeure vervielfaeltigungsverfahren auf basis der ramifikations-extensions-amplifizierung (ram) und der in vitro transkription | |
| CA2956925C (en) | Tagging nucleic acids for sequence assembly | |
| DE69713599T2 (de) | Verfahren zur bestimmung von nukleinsäure-sequenzen und diagnostische anwendungen derselben | |
| DE69421277T2 (de) | NUKLEINSäURE-SEQUENZANALYSE DURCH DIE METHODE DER PARALLELEN PRIMEREXTENSION | |
| US8143388B2 (en) | Method and test kit for quantitative determination of polynucleotides in a mixture | |
| DE60213803T2 (de) | Happier mapping | |
| DE102008061772A1 (de) | Verfahren zur Untersuchung von Nukleinsäure-Populationen | |
| EP2028273A1 (de) | Verfahren zum nachweis einer infektions des urogenitalbereichs, oligonukleotid, oligonukleotidkombination, biochip und darauf basierendes set | |
| DE102005034628B4 (de) | Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA | |
| DE60221964T2 (de) | Verfahren und testkit zur quantitativen bestimmung von variationen der polynukleotidmengen in zell- oder gewebeproben | |
| DE60011177T2 (de) | Amplifikation und Detektion von Shigella spp. und enteroinvasiven Stämmen von Escherichia coli | |
| DE102011114984B3 (de) | Sequenzspezifische Analyse von Nukleinsäuren | |
| DE102008013715A1 (de) | Verfahren zur DNA-Analyse | |
| DE19635347C1 (de) | Sequentielle Hybridisierung von Pilzzellen-DNA sowie Verfahren zum Nachweisen von Pilzzellen in klinischem Material | |
| DE19801661A1 (de) | Schnell-Detektionsverfahren für Organismen durch Längenbestimmung ausgewählter Nukleinsäurebereiche | |
| EP2471955B1 (de) | Organismusspezifisches hybridisierbares Nucleinsäuremolekül | |
| DE19934510B4 (de) | Verfahren zum Nachweis von Mikroorganismen | |
| US20020086313A1 (en) | Application of bioinformatics for direct study of unculturable microorganisms | |
| DE102013213279B4 (de) | Universelles Verfahren zur Detektion von diversen Analyten in Form von Nukleinsäuresequenzen | |
| DE10215367A1 (de) | Verbessertes Verfahren zur Bestimmung von Nukleotidsequenzen | |
| EP0991781A2 (de) | Nukleinsäuremolekülsatz für salmonella-nachweis, nukleinsäuren, kit und verwendung | |
| EP1121469A2 (de) | Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |